Abstract Objective Most SARS‐CoV‐2‐infected individuals never require hospitalization.
However, some develop prolonged symptoms. We sought to characterize the spectrum of …

Objective We characterized the evolution of neurologic symptoms and self‐perceived
recovery of non‐hospitalized COVID‐19 “long haulers” 6–9 months after their initial Neuro …

ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome-related coronavirus 2 (SARS-CoV-2) has now caused over 2 million …

Since the beginning of the Coronavirus disease (COVID)-19 pandemic in December 2019,
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible …

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to an
adaptive immune response in the host and the formation of anti-SARS-CoV-2 specific …

The ongoing COVID-19 pandemic has emphasized the urgent need for rapid, accurate, and
large-scale diagnostic tools. Next to this, the significance of serological tests (ie, detection of …

The capacity of SARS-CoV-2 to evolve poses challenges to conventional prevention and
treatment options such as vaccination and monoclonal antibodies, as they rely on viral …

Background: Many studies have focused on the characteristics of symptomatic patients with
COVID-19 and clinical risk factors. This study reports the prevalence of COVID-19 in an …

Despite effective spike-based vaccines and monoclonal antibodies, the SARS-CoV-2
pandemic continues more than two and a half years post-onset. Relentless investigation has …

Background: We evaluated how plasma proteomic signatures in patients with suspected
COVID-19 can unravel the pathophysiology, and determine kinetics and clinical outcome of …